There is our fluff piece LOL
Solid to see the product working outside of the US and expand the understanding of the tool via the journals.
Highlights the benefits of the product worldwide. Would be interesting to understand the cost benefit to the patients in the US given the cost of all the testing required RE x-rays, antibiotics etc.
Ann: Lumos announces positive FebriDx paediatric study results, page-2
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 3.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 615 | 1 |
View Market Depth
| Last trade - 09.48am 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
3.3¢ |
Change
0.000 ( 0.60 %) |
||||
| Open | High | Low | Volume | ||
| 3.3¢ | 3.3¢ | 3.3¢ | 27864 | ||
| Last updated 10.04am 06/06/2024 ? | |||||
| LDX (ASX) Chart |
Day chart unavailable